CVRx, Inc. (CVRX) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel Following Revenue Guidance Cut and Sales-Execution Disclosures

Johnson Fistel is investigating CVRx, Inc. for potential securities law violations following the company's August 6, 2026 revenue guidance cut from $63-67 million to $58-60 million. The downward revision was attributed to sales force execution challenges, high employee turnover, slower productivity ramps, and reimbursement issues with a major Medicare Advantage payer. CVRx also disclosed receiving a Department of Justice civil investigative demand regarding sales and marketing practices.